Market Share of Lung Cancer Therapeutics Industry
The lung cancer therapeutics market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known including AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Pfizer Inc., Amgen Inc., and Novartis AG, among others.
Lung Cancer Therapeutics Market Leaders
-
AstraZeneca
-
Boehringer Ingelheim
-
Bristol-Myers Squibb Company
-
Novartis AG
-
Eli Lilly and Company
*Disclaimer: Major Players sorted in no particular order
